William K. Grogan - 01 Mar 2026 Form 4 Insider Report for Xylem Inc. (XYL)

Reporting relationship: EVP & Chief Financial Officer
Issuer ticker: XYL
Reported as of: 01 Mar 2026
Net transaction value: +$3,226,177
SEC form: 4
Accepted by SEC: 03 Mar 2026, 16:53:47 UTC
Prior SEC filing: 18 Sep 2025
Next SEC filing: 06 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Mike Nazario, by power of attorney for William K. Grogan

Key filing fact

William K. Grogan filed Form 4 for Xylem Inc. (XYL) on 03 Mar 2026.

Key facts

This page summarizes William K. Grogan's Form 4 filing for Xylem Inc. (XYL).
7 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 03 Mar 2026, 16:53.

Change

Previous filing in this sequence was filed on 18 Sep 2025.
Current net transaction value: +$3,226,177.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001694002 Primary reporting owner

Grogan William K

Relationship: EVP & Chief Financial Officer
Address: C/O XYLEM INC., 301 WATER STREET SE, WASHINGTON
Signature: /s/ Mike Nazario, by power of attorney for William K. Grogan
Signature date: 03 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

XYL transaction

Common Stock

Award

Transaction value: $715,968
Shares: +5,551
Change %: +20%
Price: $128.98
Shares after: 33,801
Date: 01 Mar 2026
Ownership: Direct
Footnotes: F1, F2

XYL transaction

Common Stock

Award

Transaction value: $591,115
Shares: +4,583
Change %: +14%
Price: $128.98
Shares after: 38,384
Date: 01 Mar 2026
Ownership: Direct
Footnotes: F3

XYL transaction

Common Stock

Award

Transaction value: $402,031
Shares: +3,117
Change %: +8.1%
Price: $128.98
Shares after: 41,501
Date: 01 Mar 2026
Ownership: Direct
Footnotes: F4

XYL transaction

Common Stock

Award

Transaction value: $0
Shares: +5,116
Change %: +12%
Price: $0.000000
Shares after: 46,617
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F5

XYL transaction

Common Stock

Tax liability

Transaction value: $759,434
Shares: -5,888
Change %: -13%
Price: $128.98
Shares after: 40,729
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F6

XYL transaction

Common Stock

Tax liability

Transaction value: $74,550
Shares: -578
Change %: -1.4%
Price: $128.98
Shares after: 40,151
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F7

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

XYL transaction Derivative

Non-Qualified Stock Option (Right to Buy)

Award

Transaction value: $2,351,047
Shares: +18,228
Change %
Price: $128.98
Shares after: 18,228
Date: 02 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 18,228
Exercise price: $128.98
Footnotes: F8

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 8 footnotes

Footnote F1

Reflects the acquisition of 5,551 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return.

Footnote F2

Includes additional shares due to dividend reinvestment.

Footnote F3

Reflects the acquisition of 4,583 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Adjusted EBITDA.

Footnote F4

Reflects the acquisition of 3,117 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue.

Footnote F5

Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2027, March 1, 2028 and March 1, 2029.

Footnote F6

Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24 2016).

Footnote F7

Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2024 (578) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).

Footnote F8

Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028 and March 1, 2029.